BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9243327)

  • 1. Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogs.
    Inami M; Kawamura I; Naoe Y; Tsujimoto S; Mizota T; Manda T; Shimomura K
    Jpn J Pharmacol; 1997 Jun; 74(2):187-94. PubMed ID: 9243327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.
    Hirosumi J; Nakayama O; Chida N; Inami M; Fagan T; Sawada K; Shigematsu S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):365-73. PubMed ID: 7734405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.
    Hirosumi J; Nakayama O; Fagan T; Sawada K; Chida N; Inami M; Takahashi S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):357-63. PubMed ID: 7734404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic study of a new nonsteroidal 5 alpha-reductase inhibitor, 4-[3-[3-[Bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-yl]-butyr ic acid, in rats.
    Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):914-20. PubMed ID: 9495849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-(1-benzoylindol-3-yl)butyric acids and FK143: novel nonsteroidal inhibitors of steroid 5 alpha-reductase (II).
    Sawada K; Okada S; Golden P; Kayakiri N; Sawada Y; Hashimoto M; Tanaka H
    Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):481-91. PubMed ID: 10319427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
    Yasuda N; Fujino K; Shiraji T; Nambu F; Kondo K
    Jpn J Pharmacol; 1997 Jul; 74(3):243-52. PubMed ID: 9268084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
    Kojo H; Nakayama O; Hirosumi J; Chida N; Notsu Y; Okuhara M
    Mol Pharmacol; 1995 Sep; 48(3):401-6. PubMed ID: 7565619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution kinetics of a new nonsteroidal 5 alpha-reductase [correction of 5 A-reductase] inhibitor, 4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-YL ]-butyric acid, in rats.
    Katashima M; Yamamoto K; Haraguchi K; Tokuma Y; Hata T; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Sep; 25(9):1051-8. PubMed ID: 9311620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
    Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
    Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143.
    Homma Y; Kaneko M; Kondo Y; Kawabe K; Kakizoe T
    J Natl Cancer Inst; 1997 Jun; 89(11):803-7. PubMed ID: 9182979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
    Murakoshi M; Tagawa M; Ikeda R
    J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
    Juniewicz PE; McCarthy M; Lemp BM; Barbolt TA; Shaw C; Hollenbaugh DM; Winneker RC; Reel JR; Batzold FH
    Endocrinology; 1990 May; 126(5):2625-34. PubMed ID: 1691701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
    Murakoshi M; Ikeda R; Fukui N
    J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
    Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.
    Maruyama S; Nagasue N; Dhar DK; Yamanoi A; El-Assal ON; Satoh K; Okita K
    Clin Cancer Res; 2001 Jul; 7(7):2096-104. PubMed ID: 11448929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M; Ikeda R; Fukui N; Nakayama T
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
    Murakoshi M; Ikada R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic oral administration of a selective 5 alpha-reductase inhibitor, finasteride, on the dog prostate.
    Laroque PA; Prahalada S; Gordon LR; Noblot SM; Bagdon WJ; Duprat P; Peter CP; Van Zwieten MJ
    Prostate; 1994; 24(2):93-100. PubMed ID: 8309848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
    Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
    Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.